Outcomes of Systemic Targeted Therapy in Recurrent RCC Treated With Adjuvant Sunitinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Outcomes of Systemic Targeted Therapy in Recurrent Renal Cell Carcinoma Treated With Adjuvant Sunitinib
BJU Int 2021 Feb 06;[EPub Ahead of Print], G de Velasco, Á Ruiz-Granados, O Reig, F Massari, MA Climent Duran, E Verzoni, J Graham, R Llarena, M De Tursi, F Donskov, C Iglesias, HS Pandha, XG Del Muro, G Procopio, S Oudard, D Castellano, L AlbigesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.